Coloni G F, Lococo A, Battaglia C, Crisci R, Di Ignazio D
Minerva Med. 1983 Mar 31;74(13):695-8.
Twenty-two patients with surgically incurable lung cancer undergoing systemic chemotherapy have been studied with serial determinations of CEA levels during their therapy. The changes of CEA levels in each patients showed that the assay may be useful to evaluate the effects of therapy. The purpose of this preliminary study is to explore the possibility that CEA assay may be a useful guide to the subsequent clinical response of the patient to the drug.
对22例接受全身化疗且手术无法治愈的肺癌患者在治疗期间进行了癌胚抗原（CEA）水平的系列测定。每位患者CEA水平的变化表明，该检测可能有助于评估治疗效果。这项初步研究的目的是探索CEA检测可能成为患者对药物后续临床反应有用指导的可能性。
